BR0014591A - Polymorphic n- [3 - [[2- (3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride - Google Patents

Polymorphic n- [3 - [[2- (3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride

Info

Publication number
BR0014591A
BR0014591A BR0014591-2A BR0014591A BR0014591A BR 0014591 A BR0014591 A BR 0014591A BR 0014591 A BR0014591 A BR 0014591A BR 0014591 A BR0014591 A BR 0014591A
Authority
BR
Brazil
Prior art keywords
polymorphic
dimethoxyphenyl
propyl
ethyl
amino
Prior art date
Application number
BR0014591-2A
Other languages
Portuguese (pt)
Inventor
David Busby
Original Assignee
Glaxosmithkline Lab Sas
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Lab Sas, Smithkline Beecham Plc filed Critical Glaxosmithkline Lab Sas
Publication of BR0014591A publication Critical patent/BR0014591A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"CLORIDRATO POLIMóRFICO DE N-[3-[[2-(3,4- DIMETOXIFENIL)ETILIAMINO]PROPIL]-4-NITRO BENZAMIDA". Forma polimórfica de cloridrato de N-[3-[[2-(3,4dimetoxifenil)etillaminolpropil]-4-nitrobenzamida, processo para preparação de tal composto e uso do mesmo na medicina."N- [3 - [[2- (3,4-DIMETOXYphenyl) ETHYLAMINE] PROPIL] -4-NITRO BENZAMIDE POLYMORPHIC CHLORIDATE." Polymorphic form of N- [3 - [[2- (3,4dimethoxyphenyl) ethylaminolpropyl] -4-nitrobenzamide hydrochloride, process for preparing such a compound and using it in medicine.

BR0014591-2A 1999-10-08 2000-10-06 Polymorphic n- [3 - [[2- (3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride BR0014591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923933.7A GB9923933D0 (en) 1999-10-08 1999-10-08 Novel pharmaceutical
PCT/GB2000/003847 WO2001027071A1 (en) 1999-10-08 2000-10-06 Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride

Publications (1)

Publication Number Publication Date
BR0014591A true BR0014591A (en) 2002-06-11

Family

ID=10862442

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014591-2A BR0014591A (en) 1999-10-08 2000-10-06 Polymorphic n- [3 - [[2- (3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride

Country Status (18)

Country Link
EP (1) EP1218334A1 (en)
JP (1) JP2003511437A (en)
KR (1) KR20020043618A (en)
CN (1) CN1384817A (en)
AU (1) AU7546000A (en)
BR (1) BR0014591A (en)
CA (1) CA2386845A1 (en)
CZ (1) CZ20021189A3 (en)
GB (1) GB9923933D0 (en)
HK (1) HK1049147A1 (en)
HU (1) HUP0203582A2 (en)
IL (1) IL148966A0 (en)
MX (1) MXPA02003516A (en)
NO (1) NO20021639L (en)
PL (1) PL354137A1 (en)
TR (1) TR200200949T2 (en)
WO (1) WO2001027071A1 (en)
ZA (1) ZA200202679B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7227033B2 (en) 2002-01-09 2007-06-05 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
DK2091910T3 (en) * 2006-12-06 2014-12-01 Conatus Pharmaceuticals Inc Crystalline forms of (3S) -3- [N- (N '- (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2', 3 ', 5', 6'-tetrafluorophenoxy) -4-oxopentanoic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (en) * 1994-10-26 1998-01-02 Smithkline Beecham Lab NOVEL ARRHYTHMIC AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR PREPARING THEM
GB9706376D0 (en) * 1997-03-27 1997-05-14 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
GB9923933D0 (en) 1999-12-08
EP1218334A1 (en) 2002-07-03
NO20021639L (en) 2002-05-30
PL354137A1 (en) 2003-12-29
WO2001027071A1 (en) 2001-04-19
HK1049147A1 (en) 2003-05-02
NO20021639D0 (en) 2002-04-05
AU7546000A (en) 2001-04-23
MXPA02003516A (en) 2004-09-10
CA2386845A1 (en) 2001-04-19
TR200200949T2 (en) 2002-08-21
IL148966A0 (en) 2002-11-10
HUP0203582A2 (en) 2004-03-01
JP2003511437A (en) 2003-03-25
ZA200202679B (en) 2003-05-28
CN1384817A (en) 2002-12-11
KR20020043618A (en) 2002-06-10
CZ20021189A3 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
AR045317A1 (en) CRYSTAL FORM OF AGONISTA DL ADRENERGIC RECEIVER B2
BR9501770A (en) Use of a compound, compound, pharmaceutical formulation and process for preparing a compound
BR0008753B1 (en) AMIDE COMPOUND, PROCESS FOR PREPARING AN AMIDE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF AN AMIDE COMPOUND
BR0307529A (en) N-phenyl-2-pyrimidine amine derivatives
PT1401445E (en) CRYSTALLINE ANTICOLINERGIC, PROCESS FOR PREPARING AND USING THE PREPARATION OF A MEDICATION
BR9910913A (en) Compound, process for the preparation of a compound, pharmaceutical formulation, use of a compound, and, process for the prophylaxis and / or treatment of clinical conditions associated with insulin resistance
MY117971A (en) Denaturants for sympathomimetic amine salts
BR0113520A (en) Process for the preparation of n-aryl anthranilic acids and their derivatives
BR0115482A (en) Improved sacralose composition and process for its preparation
BR9911182B1 (en) Biaryl-derived compounds with beta-3 adrenoreceptor agonist properties, use of a compound, pharmaceutical composition, and process for the preparation of a compound.
PT973511E (en) UTILIZATION OF SIBUTRAMINE ANALOGS TO DOWNLOAD LIPID LEVELS
BR9404809A (en) Compound, use, pharmaceutical formulation and process for preparing a compound
HUP0302553A2 (en) Salts of a isothiazole-4-carboxamide and process for their preparation and use for the preparation of anti-hyperproliferation agents
PT1037868E (en) ALPHA-HYDROXY AMINO AND HALO DERIVATIVES OF BETA-SULFONYL-HYDROXAMIC ACIDS AS MATRIX METALOPROTEINASE INHIBITORS
BR0211691A (en) Process for the preparation of tolterodine
BR0211063A (en) Salts of anticonvulsant derivatives
IT1319671B1 (en) PROCESS FOR THE PREPARATION OF (S) -N, N'-BIS (2-IDROSSI-1- (IDROSSIMETIL) ETIL) -5 - ((2-IDROSSI-1-OSSOPROPIL) AMINO)
BR0014591A (en) Polymorphic n- [3 - [[2- (3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride
IL155041A0 (en) Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds
BR9607264A (en) Compound derived from isothiurea pharmaceutical composition use of such compound and process for the preparation thereof
BR9810405A (en) Composition comprising 5- [4- [2- (n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
AR044175A1 (en) CEFEMO COMPOUNDS
BR9608820A (en) Process for the preparation of ropivacaine hydrochloride monohydrate and ropivacaine hydrochloride monohydrate
EE200200583A (en) Method for the preparation of (E) -N- (6,6-dimethyl-2-hepten-4-ynyl) -N-methyl-1-naphthalenemethanamine (terbinafine)
PL306538A1 (en) Substituted (aryloalkylaminobenzyl) amino propanamide derivatives, method of obtaining them and their application as antiepileptic, nervous system protecting and antidepressive agents

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]